Chemical Structure : RWJ 67657
CAS No.: 215303-72-3
货号: PC-60627Not For Human Use, Lab Use Only.
RWJ 67657 (JNJ 3026582) is a potent, selective, orally active p38 MAPK inhibitor that inhibits the production of TNF-α and IL-1β by LPS-stimulated human PBMCs with IC50 of 3 and 11 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥780 | In stock | |
10 mg | ¥1180 | In stock | |
25 mg | ¥2180 | In stock | |
50 mg | ¥3580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
RWJ 67657 (JNJ 3026582) is a potent, selective, orally active p38 MAPK inhibitor that inhibits the production of TNF-α and IL-1β by LPS-stimulated human PBMCs with IC50 of 3 and 11 nM, respectively.
RWJ 67657 inhibits p38α from purified LPS-activated human monocytes with IC50 of 30 nM, less potent for p38β.
RWJ 67657 also inhibits Src (IC50=5 uM), p65 Lck and no activity against other MAPKs and serine-threonine kinases.
RWJ 67657 inhibits TNF-alpha production in LPS-injected mice.
分子量 | 425.5 | |
分子式 | C27H24FN3O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol -2-yl]-3-butyn-1-ol |
1. Wadsworth SA, et al. J Pharmacol Exp Ther. 1999 Nov;291(2):680-7.
2. Schafer PH, et al. J Immunol. 1999 Jun 15;162(12):7110-9.
3. Fijen JW, et al. Clin Exp Immunol. 2001 Apr;124(1):16-20.
4. Faas MM, et al. Clin Exp Immunol. 2002 Feb;127(2):337-43.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright